175 related articles for article (PubMed ID: 17849066)
1. Activated protein C resistance test using factor VIII-deficient plasma: a new approach to the venous thrombotic risk?
André E; Hacquard M; Alnot Y; de Maistre E; Lecompte T
Thromb Haemost; 2007 Sep; 98(3):693-4. PubMed ID: 17849066
[No Abstract] [Full Text] [Related]
2. Effects of hereditary and acquired risk factors of venous thrombosis on a thrombin generation-based APC resistance test.
Curvers J; Thomassen MC; Rimmer J; Hamulyak K; van der Meer J; Tans G; Preston FE; Rosing J
Thromb Haemost; 2002 Jul; 88(1):5-11. PubMed ID: 12152677
[TBL] [Abstract][Full Text] [Related]
3. Activated protein C resistance assay detects thrombotic risk factors other than factor V Leiden.
Graf LL; Welsh CH; Qamar Z; Marlar RA
Am J Clin Pathol; 2003 Jan; 119(1):52-60. PubMed ID: 12520697
[TBL] [Abstract][Full Text] [Related]
4. Evaluating idiopathic venous thromboembolism: what is necessary, what is not.
Locke CF; Evans NC
J Fam Pract; 2003 Oct; 52(10):770-7. PubMed ID: 14529600
[No Abstract] [Full Text] [Related]
5. Activated protein C resistance, factor V Leiden and assessment of thrombotic risk.
Gilmore R; Doyle M; Holden F; White B; O'Donnell J
Ir Med J; 2008 Sep; 101(8):256-7. PubMed ID: 18990960
[TBL] [Abstract][Full Text] [Related]
6. Activated protein C resistance due to factor V Leiden, elevated coagulation factor VIII and postoperative deep vein thrombosis in late breast reconstruction with a free TRAM flap: a report of two cases.
Olsson E; Höijer P
Br J Plast Surg; 2005 Jul; 58(5):720-3. PubMed ID: 15992531
[TBL] [Abstract][Full Text] [Related]
7. [The routine coagulation tests along with activated protein C resistance (APC-R) in population of women applying for oral contraceptives].
Kostecka I; Dabrowska M; Osada J; Suchowierska M; Wołczyński S
Przegl Lek; 2001; 58(12):1038-40. PubMed ID: 12041017
[TBL] [Abstract][Full Text] [Related]
8. Is homozygosity for the HR2 haplotype a risk factor for venous thromboembolism?
Aras O; Hanson NQ; Tsai MY; Key NS
Thromb Haemost; 2002 Jan; 87(1):173-4. PubMed ID: 11848451
[No Abstract] [Full Text] [Related]
9. Acquired resistance to activated protein C (aAPCR) in multiple myeloma is a transitory abnormality associated with an increased risk of venous thromboembolism.
Elice F; Fink L; Tricot G; Barlogie B; Zangari M
Br J Haematol; 2006 Aug; 134(4):399-405. PubMed ID: 16882132
[TBL] [Abstract][Full Text] [Related]
10. Clinical evaluation of a functional prothrombin time-based assay for identification of factor V Leiden carriers in a group of Italian patients with venous thrombosis.
Gessoni G; Valverde S
Blood Coagul Fibrinolysis; 2007 Oct; 18(7):603-10. PubMed ID: 17890946
[TBL] [Abstract][Full Text] [Related]
11. Coagulation factor V and thrombophilia: background and mechanisms.
Segers K; Dahlbäck B; Nicolaes GA
Thromb Haemost; 2007 Sep; 98(3):530-42. PubMed ID: 17849041
[TBL] [Abstract][Full Text] [Related]
12. Testing for genetic predisposition to venous thrombosis.
Marques MB
MLO Med Lab Obs; 2002 Jan; 34(1):8-13; quiz 20-1. PubMed ID: 11828956
[No Abstract] [Full Text] [Related]
13. The effect of lupus anticoagulant in the second-generation assay for activated protein C resistance.
Ragland BD; Reed CE; Eiland BM; Tichenor PH; Hudson CL; Fritsma GA; Adler BK; Marques MB
Am J Clin Pathol; 2003 Jan; 119(1):66-71. PubMed ID: 12520699
[TBL] [Abstract][Full Text] [Related]
14. The factor VIII D1241E polymorphism is associated with decreased factor VIII activity and not with activated protein C resistance levels.
Scanavini D; Legnani C; Lunghi B; Mingozzi F; Palareti G; Bernardi F
Thromb Haemost; 2005 Mar; 93(3):453-6. PubMed ID: 15735794
[TBL] [Abstract][Full Text] [Related]
15. The effect of the levonorgestrel-releasing intrauterine system on the resistance to activated protein C (APC).
van Vliet HA; Tchaikovski SN; Rosendaal FR; Rosing J; Helmerhorst FM
Thromb Haemost; 2009 Apr; 101(4):691-5. PubMed ID: 19350113
[TBL] [Abstract][Full Text] [Related]
16. Is APC resistance a risk factor for venous thromboembolism in patients over 70 years?
Oger E; Lacut K; Le Gal G; Van Dreden P; Bressollette L; Scarabin PY; Leroyer C; Mottier D
Thromb Haemost; 2002 Oct; 88(4):587-91. PubMed ID: 12362228
[TBL] [Abstract][Full Text] [Related]
17. [Misleading marketing concerning thrombosis survey].
Lindmarker P
Lakartidningen; 2001 Jan; 98(3):223-4. PubMed ID: 11271591
[No Abstract] [Full Text] [Related]
18. Risk factors for thromboembolism.
Williams E
Ann Intern Med; 1999 Nov; 131(10):790; author reply 790-1. PubMed ID: 10577307
[No Abstract] [Full Text] [Related]
19. Polymorphisms in the protein C gene as risk factor for venous thrombosis.
Pomp ER; Doggen CJ; Vos HL; Reitsma PH; Rosendaal FR
Thromb Haemost; 2009 Jan; 101(1):62-7. PubMed ID: 19132190
[TBL] [Abstract][Full Text] [Related]
20. [Activated protein C resistance of an acquired nature: the potential role of hormonal treatment and of elevated factor VIII plasma levels].
Iturbe Hernández T; Varo MJ; Olave MT; Fuertes MA; Cornudella R
Rev Clin Esp; 1999 Sep; 199(9):618. PubMed ID: 10568160
[No Abstract] [Full Text] [Related]
[Next] [New Search]
